TD, I fully agree. Yet another indirect confirmation from Leo that results in the trials are looking good to great. As others have stated today; why would CTIX be tapping cash reservoirs, pre-announcing the P data release, and the Brilacidin Hidradenitis Suppurativa (B-HS) IND restart if they were not confident in the performance of the drugs. To me, nothing that CTIX is doing right now gives the slightest hint of anything but positive progress on all fronts.

I think Drano is correct in one of his responses that Leo is clearly giving us a BUY signal.